Content continues after advertisement

Cranberry Extract & UTIs in Dogs

Clinician's Brief (Capsule)

Sign in to Print/View PDF

Cranberry Extract & UTIs in Dogs

UTIs are caused by changes in a host’s immune defenses that allow microbes to adhere and persist within the urinary tract. In in vitro and in vivo studies, cranberries have been shown to affect bacterial adhesion to cells in the urinary tract wall. 

In the in vivo portion of this study, 12 client-owned dogs that had at least 3 UTIs in the previous year were divided into 2 groups. One group received cephalexin for 2 weeks; the other received powdered cranberry extract daily for 6 months. No dogs developed UTIs during the 6-month evaluation period, and no side effects were noted. 

In the in vitro portion, the bacteriostatic effects of cranberry extract and the impact on adherence of Escherichia coli to Madin-Darby canine kidney (MDCK) cells was tested on urine from 6 healthy dogs receiving cranberry extract for 60 days. After incubation with urine samples obtained at 30 and 60 days, mean E coli adherence to MDCK cells was significantly lower than adherence after incubation with the urine sample obtained before cranberry extract administration. The bacteriostasis assay showed no zone of inhibition around any of the canine urine samples. The results suggest cranberry extract does not inhibit bacterial growth but does decrease E coli adherence to MDCK cells, and that it therefore has potential clinical benefit in UTI prevention.

Cranberry extract can help fight multidrug-resistant bacteria in dogs with recurrent E coli UTIs.

Commentary

An exciting alternative to chronic antibiotic therapy, cranberry extract can help fight multidrug-resistant bacteria development in dogs with recurrent E coli UTIs. It is important to evaluate the literature behind a suggested cranberry product, as some are purported to have superior efficacy. Also, it may be prudent to prescribe cranberry extract only to dogs with recurrent E coli infections; there is a lack of evidence suggesting it will prevent all types of UTIs. As with all supplements, due diligence in finding the appropriate product is critical for success, as regulatory control is lacking.—Heather Troyer, DVM, DABVP, CVA, CVPP

References

For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Podcasts

Clinician's Brief:
The Podcast

Listen as host Beckie Mossor, RVT, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2018 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Privacy Policy (Updated 05/08/2018) Terms of Use (Updated 05/08/2018)